PA Furth


Associate Dean, Medical Center, Professor, Departments of Oncology and Medicine


Lombardi Comprehensive Cancer Center (LCCC)
General profile




During an academic career spanning more than thirty years, Priscilla A Furth has worked as a general internist, an infectious disease specialist, clinic director, NIH-funded basic science laboratory principal investigator and Associate Dean for Faculty Development.

As an investigator Furth has published over 125 papers with more than 7300 citations. She is noted for expanding the range of genetically engineered mouse models for preclinical breast cancer research, bringing the tetracycline responsive gene expression system to transgenic mice, providing new approaches for investigation of salivary gland cancer and early work on p53-independent apoptosis and 3’UTR-mediated regulation of gene expression. NIH has funded this work for over 20 years with supplementation by DOD, KOMEN foundation, and industry. Furth is currently a charter member of the Basic Mechanisms of Cancer Therapeutics NIH Study Section with continuous service on NIH, DOD and state-supported study sections since 1997 and presented as an invited speaker at international meetings since 1993.

Throughout her career Furth has engaged in work impacting trainee, faculty and institutional development. At Georgetown since 2001, she has chaired the Research, the Research Dashboard, and the Appointments and Promotions Committees, served(s) as a member of University Rank and Tenure and Tumor Biology Oversight Committees, and as Program Director of Growth Regulation, Lombardi Comprehensive Cancer Center and founded a Cancer Survivor practice. In her current position she works to expand the impact of the Faculty Development Committee on faculty life and teams with faculty and administration at both Georgetown and MedStar Health to maximize options for faculty career progression. At the University of Maryland from 1985-2001, she founded an Adult AIDS Patient Care Program that provided novel access to investigational therapies coupled with medical, social and legal support for a medically underserved and diverse population of women and men with HIV infection. Over her career she has taught and mentored at the undergraduate and graduate levels in science and medicine as well as both basic science and clinical post-doctoral fellows and junior faculty. Her trainees work in academia, government and industry within science, medicine and law.

Furth is a 2015 graduate of the Hedwig van Ameringen Executive Leadership in Academic Medicine Program. She received the 2010 Georgetown Women in Medicine Outstanding Achievement Award, the 2007 Noel Soderberg Evans Award, Washington DC for contributions to breast cancer research, the 1989 Specialist Award from University of Maryland Family Medicine Department, and the 1975 Eva A. Mooar Premium from Brown University. She was selected as a member of the World Class University at DanKook University in South Korea from 2009-2014 and was awarded an Alexander von Humboldt Fellowship in 1992 and a National Research Council Associateship in 1989. She holds three patents for her work targeting gene expression to living tissue using jet injection.

Dr. Furth is married. Her husband, two daughters, son and daughter-in-law are actively engaged in their own career development.


Download cv.doc


  • Post-doc (1989-1992) NCI, NIH, Tumor Virus Biology
  • Fellowship (1982-1985) Harvard Medical School, Infectious Disease
  • Residency (1979-1982) Mount Sinai School of Medicine, Internal Medicine
  • MD (1979) Yale University School of Medicine, Medicine
  • Sc.B. Honors (1975) Brown University, Physiological Psychology


  • French (read)
  • German (speak, read)